Innovating Works

Progredum GmbH

Desconocido
cONCReTE: DevelOpmeNt of Cancer RNA TherapEutics PROGREDUM GMBH participó en un H2020: H2020-MSCA-RISE-2019 Non-codingRNAs (ncRNAs) represent a large class of molecules that in concert regulate the expression of genes involved in the key pathways g...
2020-03-02 - 2025-10-31 | Financiado
PRISAR2: proactive monitoring of cancer as an alternative to surgery PROGREDUM GMBH participó en un H2020: H2020-MSCA-RISE-2019 From 2016 -2019, the first PRISAR consortium implemented the first Dutch RISE project of H2020 to investigate the use of imaging technologie...
2019-12-02 - 2025-03-31 | Financiado
SENATOR: Staff Exchange for Novel applications in 19f magnetic resonance imaging PROGREDUM GMBH participó en un H2020: H2020-MSCA-RISE-2019 Magnetic resonance imaging (MRI) is a leading clinical diagnostic technique, which is able to provide whole body imaging, and when individua...
2019-10-21 - 2024-04-30 | Financiado
CANCER: Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life PROGREDUM GMBH participó en un H2020: H2020-MSCA-RISE-2017 During this RISE project we aim to develop nanoparticle-based encapsulated libraries of different immunotherapeutic biomolecules for treatme...
2017-11-21 - 2023-08-31 | Financiado
CHARMED: Characterisation Of A Green Microenvironment And To Study Its Impact Upon Health and Well Being in T... PROGREDUM GMBH participó en un H2020: H2020-MSCA-RISE-2016 Our society in Europe is still under prepared for the demographic changing situation of an ageing population which began several decades ago...
2016-12-14 - 2021-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.